Inhibitor improves OS in poor-prognosis MDSMay 6, 2015AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Drug shows promise for lower-risk MDSMay 5, 2015AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Understanding the role of del(7q) in MDSMarch 26, 2015AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Iron chelation improves survival in lower-risk MDSDecember 16, 2014AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Two activin receptor fusion proteins show promise in anemiaDecember 12, 2014AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
FDA approves generic decitabine for MDSAugust 30, 2014AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyMyelodysplastic Syndrome
Drugs can increase risk of MDS and AMLAugust 7, 2014AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Inhibitor shows promise for hematologic disordersJune 24, 2014CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Group finds cancer stem cells in MDS patientsMay 16, 2014AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Testing reveals abnormalities in CN-AML/MDSApril 2, 2014AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Drug gets orphan designation for MDSOctober 4, 2013AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Despite efficacy, most patients discontinued therapyJuly 2, 2012AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
